This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Slumping TV Shows That Will Never Be Canceled

Grey's Anatomy
Network: ABC
Peak viewership: Feb. 5, 2006, 37.88 million viewers
Lowest viewership: Dec. 5, 2013, 7.02 million viewers

There wasn't so much of a decline to Shonda Rimes' breakthrough show as there were two different incarnations of it.

There are the first four seasons when the show was an absolute mainstream phenomenon that permeated the culture and filled the ether with Isiah Washington's slurs, Patrick Dempsey's McDreaminess and Katherine Heigl and Sandra Oh's film careers. This is before Kate Walsh gets spun off into Private Practice, before Eric Dane becomes McSteamy and well before Rimes gets serious with Scandal.

The reason this show survives is because much of what follows is what die-hard fans consider the good stuff. It's when the show propelled from its post-Super Bowl precipice, took a dramatic fall, dusted off and found some stability. Todd VanDerWerff at the A.V. Club provided a better summary of Grey's history and perseverance last summer than we can offer in this tiny space.

But the fact Grey's Anatomy has never wavered from its basic premise that a medical drama could also serve as a window into interpersonal and -- more importantly -- romantic relationships has won it a loyal following. It dispels the wrongheaded belief that a show primarily about romance can't be taken seriously as a drama and has filled a long-neglected (and still neglected) niche in U.S. television.

It may be fading, but it's a slow fade that could take a while. Dempsey and star Ellen Pompeo have stuck around for all 10 seasons and Sandra Oh is just getting around to leaving. The show itself, meanwhile, continues to put up ratings that fall just short of CBS' Two and A Half Men in their first half hour, but regularly beat that network's Bad Teacher in its second. It's also been regularly outperforming Fox's American Idol it its Thursday timeslot and putting the hurt on Fox's now-canceled Surviving Jack.

Private Practice is gone and Scandal may be Rimes' headline grabber, but Grey's Anatomy's spirit and fanbase remain intact and won't be going anywhere anytime soon.

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CBS $61.21 0.34%
CMCSA $55.94 0.05%
DIS $105.48 0.23%
FOXA $33.70 -0.71%
AAPL $123.25 -0.80%

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs